Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1077790
PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1077790
mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
PUBLISHED:
PAGES: 147 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Contact us about how to customize the report with add-on data.
The global mRNA vaccines and therapeutics market reached a value of US$ 54.37 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 40.55 Billion by 2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Messenger Ribonucleic Acid (mRNA) refers to a single protein-coding gene in the genome that acts as a basis for protein synthesis within the cells. mRNA vaccines and therapeutics combine the desirable immunological properties and are prepared in laboratories using mammalian cells. Some of the common types of vaccines and therapeutics include self-amplifying, non-replicating, in vivo self-replicating and in vitro dendritic cell non-replicating mRNA. They are injected into the body to trigger virus-detecting immune sensors and produce viral antigen proteins within the cells. This aids in enhancing the body's immunity by improving B- and T-cell responses.
The rising prevalence of medical ailments, such as diabetes, tuberculosis, cancer and cardiovascular diseases (CVDs), is one of the key factors driving the growth of the market. The increasing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections is also providing a boost to the market growth. In comparison to conventional medicines, mRNA vaccines and therapeutics are developed using advanced technologies that are more effective against pathogens, have higher potency, enhanced immunogenicity and are relatively more cost-effective. Additionally, improvements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market. Pharmaceutical companies are investing in mRNA technologies as they can combine multiple molecules into a therapeutic medicine, which is acting as another major growth-inducing factor. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with improvements in the healthcare technologies, are projected to drive the market further.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global mRNA vaccines and therapeutics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on vaccine type, treatment type, vaccine manufacturing, application and end-user.
Breakup by Vaccine Type:
- Self-amplifying mRNA-Based Vaccines
- Conventional Non-Amplifying mRNA-Based Vaccines
Breakup by Treatment Type:
- Bioengineered Vaccine
- Gene Therapy
- Gene Transcription
- Cell Therapy
- Monoclonal Antibody
- Others
Breakup by Vaccine Manufacturing:
- In-House
- Out-Sourced
Breakup by Application:
- Cancer
- Infectious Disease
- Gene Editing
- Protein Replacement
Breakup by End-User:
- Hospitals and Clinics
- Research Organizations
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined with some of the key players being Arcturus Therapeutics Inc., BioNTech SE, CureVac AG, eTheRNA immunotherapies NV, ethris GmbH, GlaxoSmithKline PLC, Moderna Therapeutics Inc., Translate Bio Inc., Argos Therapeutics, Inc., Sangamo Therapeutics Inc. and Pfizer Inc, etc.
Key Questions Answered in This Report:
- How the global mRNA vaccines and therapeutics market will perform in the coming years?
- What will be the key regional markets?
- What will be the impact of COVID-19 on the global mRNA vaccines and therapeutics market?
- What will be the key vaccine types in the market?
- What will be the key treatment types in the market?
- What will be the key manufacturing types in the market?
- What will be the applications in the market?
- What will be the key end-use segments in the market?
- What would be the various stages in the value chain of the industry?
- What will be the key driving factors and challenges in the industry?
- What will be the structure of the global mRNA vaccines and therapeutics market and who will be the key players?
- What would be the degree of competition in the industry?
Product Code: SR0522A159_Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Introduction to mRNA Vaccines and Therapeutics
- 5.1 History of mRNA Vaccines and Therapeutics Development
- 5.2 Incidence and Prevalence of Chronic Diseases and Major Infectious Diseases
- 5.3 Prevention and Treatment Using mRNA Vaccines and Therapeutics
- 5.3.1 mRNA Modifications
- 5.3.2 mRNA Efficiencies
- 5.3.3 Adjuvant/Stimulant and Carrier Technologies for mRNA-Based Vaccines
- 5.3.4 Carriers for mRNA-Based Protein and Antibody Therapeutics
6 Global mRNA Vaccines and Therapeutics Market
- 6.1 Market Potential Overview
- 6.2 Market Potential
- 6.3 Impact of COVID-19
- 6.4 mRNA Vaccines in Pipeline
7 Market Breakup by Vaccine Type
- 7.1 Self-amplifying mRNA-Based Vaccines
- 7.2 Conventional Non-Amplifying mRNA-Based Vaccines
8 Market Breakup by Treatment Type
- 8.1 Gene Therapy
- 8.2 Monoclonal Antibody
- 8.3 Gene Transcription
- 8.4 Cell Therapy
- 8.5 Bioengineered Vaccine
- 8.6 Others
9 Market Breakup by Vaccine Manufacturing
- 9.1 In-House
- 9.2 Out-Sourced
10 Market Breakup by Application
- 10.1 Cancer
- 10.2 Infectious Disease
- 10.3 Gene Editing
- 10.4 Protein Replacement
11 Market Breakup by End-User
- 11.1 Hospitals and Clinics
- 11.2 Research Organizations
- 11.3 Others
12 Market Breakup by Region
- 12.1 North America
- 12.1.1 Market Breakup by Country
- 12.1.1.1 United States
- 12.1.1.2 Canada
- 12.1.1 Market Breakup by Country
- 12.2 Europe
- 12.2.1 Market Breakup by Country
- 12.2.1.1 Germany
- 12.2.1.2 United Kingdom
- 12.2.1.3 France
- 12.2.1.4 Italy
- 12.2.1.5 Spain
- 12.2.1.6 Russia
- 12.2.1.7 Others
- 12.2.1 Market Breakup by Country
- 12.3 Asia Pacific
- 12.3.1 Market Breakup by Country
- 12.3.1.1 Japan
- 12.3.1.2 China
- 12.3.1.3 Australia
- 12.3.1.4 South Korea
- 12.3.1.5 India
- 12.3.1.6 Indonesia
- 12.3.1.7 Others
- 12.3.1 Market Breakup by Country
- 12.4 Latin America
- 12.4.1 Market Breakup by Country
- 12.4.1.1 Brazil
- 12.4.1.2 Mexico
- 12.4.1.3 Others
- 12.4.1 Market Breakup by Country
- 12.5 Middle East and Africa
- 12.5.1 Market Breakup by Country
13 SWOT Analysis
- 13.1 Overview
- 13.2 Strengths
- 13.3 Weaknesses
- 13.4 Opportunities
- 13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
- 15.1 Overview
- 15.2 Bargaining Power of Buyers
- 15.3 Bargaining Power of Suppliers
- 15.4 Degree of Competition
- 15.5 Threat of New Entrants
- 15.6 Threat of Substitutes
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Arcturus Therapeutics, Inc.
- 16.3.2 BioNTech SE
- 16.3.3 CureVac AG
- 16.3.4 eTheRNA immunotherapies NV
- 16.3.5 ethris GmbH
- 16.3.6 GlaxoSmithKline PLC
- 16.3.7 Moderna Therapeutics Inc.
- 16.3.8 Translate Bio Inc.
- 16.3.9 Argos Therapeutics, Inc.
- 16.3.10 Sangamo Therapeutics Inc.
- 16.3.11 Pfizer Inc.
Product Code: SR0522A159_Report
List of Figures
- Figure 1: Global: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2022-2027
- Figure 2: Global: mRNA Vaccines and Therapeutics Market Potential (Self-amplifying mRNA-Based Vaccines): Value Trends (in Billion US$), 2022-2027
- Figure 3: Global: mRNA Vaccines and Therapeutics Market Potential (Conventional Non-Amplifying mRNA-Based Vaccines): Value Trends (in Billion US$), 2022-2027
- Figure 4: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Therapy): Value Trends (in Billion US$), 2022-2027
- Figure 5: Global: mRNA Vaccines and Therapeutics Market Potential (Monoclonal Antibody): Value Trends (in Billion US$), 2022-2027
- Figure 6: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Transcription): Value Trends (in Billion US$), 2022-2027
- Figure 7: Global: mRNA Vaccines and Therapeutics Market Potential (Cell Therapy): Value Trends (in Billion US$), 2022-2027
- Figure 8: Global: mRNA Vaccines and Therapeutics Market Potential (Bioengineered Vaccine): Value Trends (in Billion US$), 2022-2027
- Figure 9: Global: mRNA Vaccines and Therapeutics Market Potential (Other Treatment Types): Value Trends (in Billion US$), 2022-2027
- Figure 10: Global: mRNA Vaccines and Therapeutics Market Potential (In-House): Value Trends (in Billion US$), 2022-2027
- Figure 11: Global: mRNA Vaccines and Therapeutics Market Potential (Out-Sourced): Value Trends (in Billion US$), 2022-2027
- Figure 12: Global: mRNA Vaccines and Therapeutics Market Potential (Cancer): Value Trends (in Billion US$), 2022-2027
- Figure 13: Global: mRNA Vaccines and Therapeutics Market Potential (Infectious Disease): Value Trends (in Billion US$), 2022-2027
- Figure 14: Global: mRNA Vaccines and Therapeutics Market Potential (Gene Editing): Value Trends (in Billion US$), 2022-2027
- Figure 15: Global: mRNA Vaccines and Therapeutics Market Potential (Protein Replacement): Value Trends (in Billion US$), 2022-2027
- Figure 16: Global: mRNA Vaccines and Therapeutics Market Potential (Hospitals and Clinics): Value Trends (in Billion US$), 2022-2027
- Figure 17: Global: mRNA Vaccines and Therapeutics Market Potential (Research Organizations): Value Trends (in Billion US$), 2022-2027
- Figure 18: Global: mRNA Vaccines and Therapeutics Market Potential (Other End-Users): Value Trends (in Billion US$), 2022-2027
- Figure 19: North America: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2022-2027
- Figure 20: North America: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2021
- Figure 21: United States: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 22: Canada: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 23: Europe: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2022-2027
- Figure 24: Europe: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2021
- Figure 25: Germany: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 26: United Kingdom: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 27: France: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 28: Italy: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 29: Spain: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 30: Russia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 31: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 32: Asia Pacific: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2022-2027
- Figure 33: Asia Pacific: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2021
- Figure 34: Japan: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 35: China: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 36: Australia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 37: South Korea: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 38: India: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 39: Indonesia: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 40: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 41: Latin America: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2022-2027
- Figure 42: Latin America: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2021
- Figure 43: Brazil: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 44: Mexico: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 45: Others: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Million US$), 2022-2027
- Figure 46: Middle East and Africa: mRNA Vaccines and Therapeutics Market Potential: Value Trends (in Billion US$), 2022-2027
- Figure 47: Middle East and Africa: mRNA Vaccines and Therapeutics Market Potential: Breakup by Country (in %), 2021
- Figure 48: Global: mRNA Vaccines and Therapeutics Market: SWOT Analysis
- Figure 49: Global: mRNA Vaccines and Therapeutics Market: Value Chain Analysis
- Figure 50: Global: mRNA Vaccines and Therapeutics Market: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: mRNA Vaccines and Therapeutics Market Potential: Key Industry Highlights, 2021 and 2027
- Table 2: Global: mRNA Vaccines and Therapeutics Market: List of Pipeline mRNA Vaccines
- Table 3: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Vaccine Type (in Billion US$), 2022-2027
- Table 4: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Treatment Type (in Billion US$), 2022-2027
- Table 5: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Vaccine Manufacturing (in Billion US$), 2022-2027
- Table 6: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Application (in Billion US$), 2022-2027
- Table 7: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by End-User (in Billion US$), 2022-2027
- Table 8: Global: mRNA Vaccines and Therapeutics Market Potential: Breakup by Region (in Billion US$), 2022-2027
- Table 9: Global: mRNA Vaccines and Therapeutics Market: Competitive Structure
- Table 10: Global: mRNA Vaccines and Therapeutics Market: List of Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.